Pathophysiology of COVID-19-associated acute respiratory distress syndrome - Authors' reply. 2021

Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

UI MeSH Term Description Entries
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
January 2021, The Lancet. Respiratory medicine,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
January 2021, The Lancet. Respiratory medicine,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
January 2021, The Lancet. Respiratory medicine,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
January 2021, The Lancet. Respiratory medicine,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
October 2021, Critical care clinics,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
July 2020, American journal of respiratory and critical care medicine,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
December 2021, Iranian journal of microbiology,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
April 2017, Lancet (London, England),
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
January 2022, Annals of the American Thoracic Society,
Giacomo Grasselli, and Tommaso Tonetti, and Claudia Filippini, and Arthur S Slutsky, and Antonio Pesenti, and V Marco Ranieri
April 2022, Expert review of respiratory medicine,
Copied contents to your clipboard!